Veritas Pharma Inc
Indigenous Bloom Hemp Corp. focuses on the production of hemp products. It sells hemp biomass and flowers, as well as phytocannabinoid rich extracts derived from hemp biomass. The company is headquartered in Kelowna, Canada.
Veritas Pharma Inc (VRTHF) - Total Liabilities
Latest total liabilities as of February 2023: $3.32 Million USD
Based on the latest financial reports, Veritas Pharma Inc (VRTHF) has total liabilities worth $3.32 Million USD as of February 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Veritas Pharma Inc - Total Liabilities Trend (2014–2022)
This chart illustrates how Veritas Pharma Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Veritas Pharma Inc Competitors by Total Liabilities
The table below lists competitors of Veritas Pharma Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Discoverie Group PLC
LSE:DSCV
|
UK | GBX378.10 Million |
|
Hyflux Ltd
PINK:HYFXF
|
USA | $2.71 Billion |
|
CLP HLDGS
MU:CLP
|
Germany | €116.67 Billion |
|
Invictus Financial Inc
PINK:IVFZF
|
USA | $570.84K |
Liability Composition Analysis (2014–2022)
This chart breaks down Veritas Pharma Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 5.92 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Veritas Pharma Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Veritas Pharma Inc (2014–2022)
The table below shows the annual total liabilities of Veritas Pharma Inc from 2014 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-05-31 | $3.21 Million | +147.86% |
| 2021-05-31 | $1.30 Million | +44.42% |
| 2020-05-31 | $896.69K | -1.06% |
| 2019-05-31 | $906.28K | +361.37% |
| 2018-05-31 | $196.43K | +21.45% |
| 2017-05-31 | $161.74K | +99.89% |
| 2016-05-31 | $80.91K | -62.91% |
| 2015-05-31 | $218.13K | +2280.30% |
| 2014-05-31 | $9.16K | -- |